Financials Nissan Medical Industries Ltd
Equities
NISA
IL0006600196
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,392 ILa | +0.36% | -1.28% | +28.89% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 250.3 | 122.4 | 259.6 | 199 | 78.05 | 98.1 |
Enterprise Value (EV) 1 | 548.9 | 391.8 | 451.4 | 399.7 | 309.6 | 271.3 |
P/E ratio | 9.97 x | 7.79 x | 4.57 x | 5.57 x | -2.16 x | 17.4 x |
Yield | - | - | 3.5% | 2.01% | - | - |
Capitalization / Revenue | 0.38 x | 0.2 x | 0.36 x | 0.3 x | 0.11 x | 0.13 x |
EV / Revenue | 0.83 x | 0.65 x | 0.63 x | 0.6 x | 0.45 x | 0.37 x |
EV / EBITDA | 6.32 x | 5.99 x | 3.28 x | 4.56 x | 13.9 x | 3.12 x |
EV / FCF | 11.2 x | 14.4 x | 6.17 x | -291 x | -68.6 x | 5.02 x |
FCF Yield | 8.94% | 6.94% | 16.2% | -0.34% | -1.46% | 19.9% |
Price to Book | 1.46 x | 0.71 x | 1.24 x | 0.87 x | 0.36 x | 0.43 x |
Nbr of stocks (in thousands) | 9,084 | 9,084 | 9,084 | 9,084 | 9,084 | 9,084 |
Reference price 2 | 27.56 | 13.47 | 28.58 | 21.91 | 8.593 | 10.80 |
Announcement Date | 20/03/19 | 25/03/20 | 16/03/21 | 28/03/22 | 31/03/23 | 20/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 658.4 | 605.5 | 721.5 | 668.4 | 684.6 | 733.9 |
EBITDA 1 | 86.85 | 65.37 | 137.8 | 87.68 | 22.25 | 86.9 |
EBIT 1 | 60.67 | 36.68 | 110.3 | 65.81 | -1.766 | 61.37 |
Operating Margin | 9.21% | 6.06% | 15.29% | 9.85% | -0.26% | 8.36% |
Earnings before Tax (EBT) 1 | 50.56 | 30.91 | 110 | 70.45 | -47.02 | 27.82 |
Net income 1 | 25.1 | 15.71 | 56.85 | 36.01 | -36.05 | 5.649 |
Net margin | 3.81% | 2.59% | 7.88% | 5.39% | -5.27% | 0.77% |
EPS 2 | 2.763 | 1.729 | 6.258 | 3.935 | -3.970 | 0.6219 |
Free Cash Flow 1 | 49.1 | 27.21 | 73.13 | -1.372 | -4.512 | 54.04 |
FCF margin | 7.46% | 4.49% | 10.14% | -0.21% | -0.66% | 7.36% |
FCF Conversion (EBITDA) | 56.53% | 41.62% | 53.09% | - | - | 62.19% |
FCF Conversion (Net income) | 195.59% | 173.19% | 128.65% | - | - | 956.66% |
Dividend per Share | - | - | 1.000 | 0.4400 | - | - |
Announcement Date | 20/03/19 | 25/03/20 | 16/03/21 | 28/03/22 | 31/03/23 | 20/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 299 | 269 | 192 | 201 | 232 | 173 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3.438 x | 4.121 x | 1.392 x | 2.289 x | 10.41 x | 1.993 x |
Free Cash Flow 1 | 49.1 | 27.2 | 73.1 | -1.37 | -4.51 | 54 |
ROE (net income / shareholders' equity) | 16.3% | 9.36% | 31.1% | 17.1% | -14% | 5.54% |
ROA (Net income/ Total Assets) | 5.29% | 3.21% | 9.92% | 5.75% | -0.15% | 5.32% |
Assets 1 | 474.9 | 488.7 | 573.2 | 626.3 | 23,953 | 106.2 |
Book Value Per Share 2 | 18.90 | 19.00 | 23.10 | 25.10 | 23.70 | 25.20 |
Cash Flow per Share 2 | 1.580 | 2.370 | 5.350 | 4.410 | 2.130 | 2.740 |
Capex 1 | 11.9 | 10.1 | 13.9 | 8.16 | 9.18 | 9.82 |
Capex / Sales | 1.8% | 1.67% | 1.92% | 1.22% | 1.34% | 1.34% |
Announcement Date | 20/03/19 | 25/03/20 | 16/03/21 | 28/03/22 | 31/03/23 | 20/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+28.89% | 33.75M | |
+8.34% | 27.27B | |
-30.75% | 3.12B | |
-15.97% | 2.53B | |
+18.11% | 2.47B | |
+3.70% | 2B | |
-9.47% | 1.91B | |
-2.22% | 1.48B | |
+2.91% | 1.3B | |
+18.92% | 1.18B |
- Stock Market
- Equities
- NISA Stock
- Financials Nissan Medical Industries Ltd